Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Novocol Pharmaceutical of Canada, Inc. | Cambridge, Canada | Makes it | Problems found, fixed voluntarilyMay 3, 2024 · 11 inspections |
Recalls
- Nov 20, 2020 · Class III · Novocol Pharmaceutical of Canada, Inc.
Labeling: Label mix-up
Lots: Batch # D03050E, D03032F, Exp 28-Feb-2022; D02983D, Exp 30-Nov-2021; D02865C, Exp 31-Aug-2021; D02894G, Exp 30-Sep-2021; D02701G, Exp 31-Jan-2021; D02766E, Exp 30-Apr-2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Mepivacaine: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 30 mg per 1 mL
- Approval
- ANDA ANDA088387
- On the market since
- Dec 22, 2017
- Package NDCs
0362-1098-90- Official label
- DailyMed (National Library of Medicine), updated May 29, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?